Ignite Creation Date:
2025-12-24 @ 4:33 PM
Ignite Modification Date:
2026-02-25 @ 9:49 PM
Study NCT ID:
NCT00495066
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2013-06-03
First Post:
2007-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Compassionate Use Trial for Unresectable Melanoma With Ipilimumab
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA184-045
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None